Oxurion NV Logo

Oxurion NV

Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.

OXUR | BR

Overview

Corporate Details

ISIN(s):
BE0974487192
LEI:
549300VWY8KVDFKLDM59
Country:
Belgium
Address:
Gaston Geenslaan 1, 3001 Heverlee
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Oxurion is a company specializing in acquiring majority stakes in promising European pharmaceutical subcontractors. Its ambition is to build an integrated group of subcontractors to serve healthcare stakeholders. The company holds a 72% stake in Axiodis CRO, a contract research organization specialized in biometrics. This strategy represents a shift from its historical focus as a biopharmaceutical company developing therapies for retinal diseases like Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-02 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20251002.pdf
English 352.2 KB
2025-10-02 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20251002.pdf
Dutch 378.2 KB
2025-09-30 18:00
Interim Report
OXUR GLOBAL - Financial report 30-06-2025 (EN) FINAL.pdf
English 412.9 KB
2025-09-30 18:00
Interim Report
OXUR GLOBAL - Financial report 30-06-2025 (NL) FINAL.pdf
Dutch 420.8 KB
2025-09-30 18:00
Report Publication Announcement
OXUR_Publish-H1-2025-results_EN.pdf
English 211.4 KB
2025-09-30 18:00
Report Publication Announcement
OXUR_Publication-H1-2025-resultats_FR.pdf
French 161.8 KB
2025-09-30 18:00
Report Publication Announcement
OXUR_Publicatie-H1-2025-resultaten_NL.pdf
Dutch 211.0 KB
2025-09-08 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20250903.pdf
English 371.9 KB
2025-09-08 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20250903.pdf
Dutch 396.3 KB
2025-09-01 18:00
Capital/Financing Update
OXUR-Contrat-atlas-crypto-EN-20250901.pdf
English 190.2 KB
2025-09-01 18:00
Capital/Financing Update
OXUR-Contrat-atlas-crypto-FR-20250901.pdf
French 125.2 KB
2025-09-01 18:00
Capital/Financing Update
OXUR-Contrat-atlas-crypto-NL-20250901-1.pdf
Dutch 214.2 KB
2025-09-01 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-EN-20250901.pdf
English 1.2 MB
2025-09-01 18:00
Major Shareholding Notification
OXUR-Transparency-Notification-NL-20250901.pdf
English 1.3 MB
2025-08-07 18:00
Legal Proceedings Report
OXUR-New-Development-Strategy-EN-20250806.pdf
English 195.7 KB

Automate Your Workflow. Get a real-time feed of all Oxurion NV filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Oxurion NV via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-03-07 Bareldam SA Close relation Buy 1,180,555 1,700,000.00 EUR
2021-09-30 Lavinia D. Clay 2009 Revocable Trust Close relation Other 2,766,337 5,601,002.52 EUR

Peer Companies

Company Country Ticker View
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea 187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea 048410
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea 456570
Immunic AG Logo
Developing oral therapies for autoimmune diseases like multiple sclerosis and celiac disease.
United States of America IMUX
Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.
Japan 6535
INBIOGEN CO.,Ltd Logo
Data mining, bioinformatics, and virtual assistance for the life sciences industry.
South Korea 101140
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea 216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan 7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France IPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.